AbbVie Inc. — Director's Dealing 2026

Feb 27, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2026-02-25

Reporting Person: Siatis Perry C (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-02-25	Common Stock, $0.01 par value	M	7314	$149.62	Acquired	45451	Direct
2026-02-25	Common Stock, $0.01 par value	M	7775	$175.28	Acquired	53226	Direct
2026-02-25	Common Stock, $0.01 par value	M	7292	$192.86	Acquired	60518	Direct
2026-02-25	Common Stock, $0.01 par value	S	22381	$230	Disposed	38137	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-02-25	Option (Right to buy)	$149.62	M	7314	Disposed	2033-02-15	Common Stock (7314)	Direct
2026-02-25	Option (Right to buy)	$175.28	M	7775	Disposed	2034-02-14	Common Stock (7775)	Direct
2026-02-25	Option (Right to buy)	$192.86	M	7292	Disposed	2035-02-12	Common Stock (7292)	Direct

Footnotes

F1: Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable in annual increments of 7,315 on February 16, 2024, 7,315 on February 16, 2025, and 7,314 on February 16, 2026.

F2: Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable in annual increments of 7,775 on February 15, 2025 and 7,775 on February 15, 2026, and becomes exercisable as to 7,774 shares on February 15, 2027.

F3: Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 7,292 shares on February 13, 2026 and becomes exercisable in annual increments of 7,292 on February 13, 2027, and 7,291 on February 13, 2028.